Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Lyme disease - Drugs in this topic
Scenario: Lyme disease

This level contains the following sections:

  • Amoxicillin 125mg/5ml oral suspension sugar free
  • Amoxicillin 250mg/5ml oral suspension sugar free
  • Amoxicillin 500mg capsules
  • Cefuroxime 125mg/5ml oral suspension
  • Cefuroxime 250mg tablets
  • Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free
  • Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free
  • Co-amoxiclav 500mg/125mg tablets
  • Doxycycline 100mg capsules
  • Flucloxacillin 125mg/5ml oral solution
  • Flucloxacillin 250mg/5ml oral suspension
  • Flucloxacillin 500mg capsules

© NHS Institute for Innovation and Improvement